These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 411951)

  • 21. Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
    Doongaji DR; Satoskar RS; Sheth AS; Apte JS; Desai AB; Shah BR
    J Postgrad Med; 1989 Jan; 35(1):3-8. PubMed ID: 2685263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of thiothixene on schizophrenic symptoms in a long-term therapeutic scheme. Comparative study with butyrophenone derivative].
    Vianna Filho U; Muniz AF; Terra SO; Bueno JR
    J Bras Psiquiatr; 1971; 20(3):193-204. PubMed ID: 5164436
    [No Abstract]   [Full Text] [Related]  

  • 23. Qualitative and quantitative EEG changes of intramuscular thiothixene and trifluoperazine in chronic schizophrenia.
    Akpinar S; Itil TM; Holden JM; Hsu W
    Dis Nerv Syst; 1972 Jan; 33(1):40-5. PubMed ID: 5059688
    [No Abstract]   [Full Text] [Related]  

  • 24. Distractibility in schizophrenia.
    Bergman A; O'Brien J; Osgood G; Cornblatt B
    Psychiatry Res; 1995 Jul; 57(2):131-40. PubMed ID: 7480380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind comparison of thiothixene, trifluoperazine, and placebo in chronic alcoholism.
    Butterworth AT; Watts RD
    Psychosomatics; 1974; 15(2):85-7. PubMed ID: 4606450
    [No Abstract]   [Full Text] [Related]  

  • 26. Thiothixene. Its range of therapeutic activity.
    Oliveros RT; Ban TA; Lehmann HE; Sterlin C; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):26-9. PubMed ID: 4909376
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise.
    Carlsson C; Dencker SJ; Grimby G; Häggendal J; Johnsson G
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):262-8. PubMed ID: 965133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictor patterns in the management of therapy-resistant schizophrenia.
    Holden JM; Hsu W; Itil TM; Keskiner A
    Dis Nerv Syst; 1971 Apr; 32(4):260-8. PubMed ID: 4397410
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB; Patel Y
    Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New onset Raynaud's phenomenon in a schizophrenic patient.
    McCance-Katz EF
    J Clin Psychiatry; 1991 Feb; 52(2):89-90. PubMed ID: 1993645
    [No Abstract]   [Full Text] [Related]  

  • 31. The place of thiothixene among the thioxanthenes.
    Sterlin C; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):205-14. PubMed ID: 4623599
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 33. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971; 3(5):25-32. PubMed ID: 4948596
    [No Abstract]   [Full Text] [Related]  

  • 35. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 36. Intramuscular thiothixene in acute psychotic states.
    de Silva FP; Carr SL; Polonowita A
    N Z Med J; 1980 Dec; 92(674):459-61. PubMed ID: 6937789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some clinical and physiologic effects of a thioxanthene derivative, thiothixene (P-4657B), in 20 newly hospitalized male schizophrenics.
    Hekimian LJ; Gershon S; Floyd A
    J Clin Pharmacol J New Drugs; 1967; 7(1):52-7. PubMed ID: 5317542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of thiothixene with chlorpromazine in the treatment of mania.
    Janicak PG; Bresnahan DB; Sharma R; Davis JM; Comaty JE; Malinick C
    J Clin Psychopharmacol; 1988 Feb; 8(1):33-7. PubMed ID: 3280617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of thiothixene capsules and concentrate in acutely schizophrenic patients.
    Goldstein BJ
    Psychosomatics; 1970; 11(5):434-7. PubMed ID: 5470669
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene.
    Kim DY; Hollister LE
    J Clin Psychopharmacol; 1984 Feb; 4(1):32-5. PubMed ID: 6693581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.